C2i Genomics
Offers post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$400—600m (Dealroom.co estimates Apr 2021.)
New York City New York (HQ)
Authorizing premium user...